Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    Plastics in Transition

    Technology insight report on plastic waste management

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisions”

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventor Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Water-related technologies
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • Communiqués
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
Website
cancel
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
    • Go back
    • New to patents
  • New to patents
    • Go back
    • Your business and patents
    • Why do we have patents?
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Is it patentable?
    • Are you first?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux préparatoires to UP and UPC
      • National measures relating to the Unitary Patent 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • 2024 activities
        • 2025 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Water-related technologies
      • CodeFest
        • Go back
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • Daily D questions
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • The PATLIB Knowledge Transfer to Africa initiative (KT2A)
          • KT2A core activities
          • Success story: Malawi University of Science and Technology and PATLIB Birmingham
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • Communiqués
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Innovation against cancer
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Tools
        • Go back
        • Overview
        • Deep Tech Finder
      • About the Observatory
        • Go back
        • Overview
        • Work plan
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Catalyst lab & Deep vision
          • Go back
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • Péter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 1990/18 (Animal models/KYMAB) 05-11-2021
Facebook X Linkedin Email

T 1990/18 (Animal models/KYMAB) 05-11-2021

European Case Law Identifier
ECLI:EP:BA:2021:T199018.20211105
Date of decision
05 November 2021
Case number
T 1990/18
Petition for review of
-
Application number
12171793.8
IPC class
A01K 67/027
C07K 16/00
C07K 16/46
C12N 15/85
Language of proceedings
EN
Distribution
NO DISTRIBUTION (D)

Download and more information:

Decision in EN 425.13 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

Animal models and therapeutic molecules

Applicant name
Kymab Limited
Opponent name
Regeneron Pharmaceuticals, Inc.
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 54(3)
European Patent Convention Art 123(2)
Rules of procedure of the Boards of Appeal Art 12(4)
Rules of procedure of the Boards of Appeal Art 13(1)
Rules of procedure of the Boards of Appeal Art 13(2)
Keywords

Amendments - added subject-matter (no)

Novelty - (yes)

Catchword
-
Cited decisions
T 1439/16
Citing decisions
-

I. European patent 2 517 557, entitled "Animal models and therapeutic molecules" was granted for European patent application No. 12 171 793.8.

II. An appeal was filed by the opponent (appellant) against the opposition division's interlocutory decision that the patent as amended in the form of the main request met the requirements of the EPC. The patent proprietor is the respondent to this appeal.

III. Claim 1 of the main request considered allowable by the opposition division reads:

"1. A mouse or mouse cell whose genome comprises:

(a) a plurality of human IgH V regions, one or more human D regions and one or more human J regions upstream of the mouse constant region;

wherein at least one mouse enhancer is maintained in functional arrangement with the mouse constant region

and wherein the insertion of the human DNA is targeted to the region between the J4 exon and the Cmu locus in the mouse genome IgH locus

and

(b) human lambda region variable DNA inserted in functional arrangement with a mouse kappa constant region, upstream of said kappa constant region; wherein at least one mouse enhancer is maintained in functional arrangement with the mouse constant region;

wherein the mouse is able to produce a repertoire of chimaeric antibodies, or chimaeric heavy or light chains having a mouse constant region and a human variable region

and wherein the genome is homozygous at one, or both, or all three immunoglobulin loci".

IV. The respondent replied to the statement of grounds of appeal and with this reply submitted sets of claims of a new main request and new auxiliary requests 1 to 3. Furthermore, the respondent re-filed the sets of claims of auxiliary requests 4 to 7 (identical to auxiliary requests 1 to 5 filed during the opposition proceedings) and of auxiliary requests 8 and 9 (identical to the main request considered by the opposition division and auxiliary request 3 filed during opposition proceedings, respectively).

V. The board issued a communication pursuant to Article 15(1) RPBA which set out the board's preliminary view that claim 1 of the main request met the requirements of Articles 123(2) EPC and 54 EPC and also that objections under Articles 56 and 83 EPC, briefly mentioned in the statement of grounds of appeal without any indication of reasons, did not meet the requirements under Article 12(2) RPBA 2007 and were considered as not substantiated and would not to be taken account in these appeal proceedings in accordance with Article 12(4) RPBA 2007.

VI. With a letter dated 3 November 2021, the respondent withdrew the main request and auxiliary request 2. Auxiliary request 1 filed with the statement of grounds of appeal became the main request. Auxiliary requests 3 to 9 filed with the reply to the statement of grounds of appeal were renumbered as auxiliary requests 1 to 7, respectively.

VII. The set of claims of the main request consists of fourteen claims. Claim 1 being directed to a mouse or mouse cell, claims 2 to 7, 9 and 11 to 13 being dependent on claim 1, claim 8 relating to an immortalised cell or cell line and claims 10 and 14 being for a method for producing an antibody. Since objections in the appeal were directed only against claim 1, it is not necessary to reproduce the wording of claims 2 to 14 here.

VIII. Claim 1 of the main request differs from claim 1 of the claim request held allowable by the opposition division (see section III) in that, in the final line of the claim "or all three" is deleted and the feature "wherein the constant region is the endogenous host wild-type constant region located at the wild type locus" is inserted after the feature (b).

IX. Oral proceedings were held by videoconference, as requested by the parties. At the end of the proceedings the Chair announced the decision of the board.

X. The following documents are referred to in this decision.

D1: WO 2001/163314

D4: US 6 596 541

D27: Declaration of Professor Anthony DeFranco

XI. The arguments of the appellant are summarised as follows:

Main request

Admittance of allegations of fact and related lines of argument (Article 13(1) and (2) RPBA)

The submissions made at the oral proceedings under the headings of Articles 54, 84 and 123(2) EPC in relation to the main request should be taken into account by the board.

The submissions made at the oral proceedings relating to the feature added to claim 1 as compared to claim 1 of the main request underlying the decision under appeal, could not have been raised in the statement of grounds of appeal since the relevant claim request had only been filed with the reply thereto and had been promoted the main request at the very last moment before the oral proceedings.

In relation to the objections under Article 123(2) EPC, the arguments relating to (i) the combination of the "LoK" feature with the "heavy chain" feature in part (a) of the claim and (ii) the combination of the "LoK" feature with the "homozygous" feature had been made in writing - at least in outline - since a fundamental argument in the statement of grounds of appeal had been that the "overall combination of features of claim 1 as upheld does not find basis in the application as filed".

It was permissible to present the objections under Article 84 EPC at the oral proceedings since the request containing the claim with the unclear feature had only been filed with the respondent's reply to the appeal. There was no fixed time limit for an appellant to submit objections to such a claim request. Furthermore, explanations from the respondent for this request were only provided with letter dated 3 November 2021, in which was it stated for the first time what the feature was supposed to mean. The submissions made at the oral proceedings were therefore a prompt reaction. Finally, the objections to novelty made at the oral proceedings were merely an extension of those already made in the statement of grounds of appeal.

Amendments (Article 123(2) EPC) - claim 1

The homozygosity feature

It was not disputed that the objection previously raised against claim 1 of main request held allowable by the opposition division had been overcome by amendment.

The location of the light chain lambda into kappa (LoK) feature in the mouse genome

The arguments under Article 123(2) EPC not rendered moot by the amendments made in the present main request were as follows:

If the LoK arrangement in feature (b) were at the endogenous position of kappa in the host genome, this was not only a selection of a specific position from an unlimited list of positions but also a further selection of a particular sub-type of LoK arrangement. That is, an arrangement in which the mouse kappa sequences of the LoK are not part of the DNA that is to be inserted, but are kappa sequences that are already present in the host genome. Thus, the feature resulted from an impermissible selection from (at least) two lists in the combination of features represented by the light chain modification of feature (b).

In addition, claim 1 as considered allowable by the opposition division in feature (b) required the insertion of "human lambda region variable DNA". By contrast, the alleged basis, i.e. feature (b) at the bottom of page 14 explicitly specified the insertion of "one or more human Ig light chain lambda V regions and one or more human Ig light chain lambda J regions" (or corresponding kappa V or J regions). There was no disclosure of any alternative amount of human light chain sequence. The exclusion of this limitation from claim 1 as considered allowable therefore added subject-matter.

Novelty (Article 54 EPC)

Contrary to the finding in the decision under appeal, the homozygosity feature could not render the claimed mouse/mouse cell novel as it was implicit that the mice disclosed in document D1 had this feature. Homozygosity was the inevitable result of following the breeding scheme disclosed in paragraph [00267] of document D1.

The skilled person would have understood that a "suitable breeding schedule", referred to in that paragraph, at the very least required breeding to homozygosity in at least one of the immunoglobulin loci and included further routine steps to introduce homozygosity also at the third locus (see document D27). Mice homozygous for at least one or two immunoglobulin loci would have been obtained with only a single, additional (and routine) breeding step - specifically a cross between F1 offspring (themselves disclosed in document D1). Such a step (interbreeding between the F1 mice) would happen by default if the F1 mice were simply left unattended.

In short document D27 demonstrated that:

(i) the nature of a suitable breeding schedule is one which leads to homozygosity at all three immunoglobulin loci;

(ii) this would have been immediately apparent to the skilled person reading document D1;

(iii) such a schedule required only the application of highly routine principles of mouse breeding; and

(iv) as a consequence of the above, homozygous mice would have been the inevitable result.

Thus, the disclosure in document D1 anticipated the subject-matter of claim 1.

Article 56 and Article 83 EPC

The claimed subject-matter lacked inventive step and/or the claimed invention was insufficiently disclosed in the patent or application, respectively, for essentially the reasons as set out during the opposition proceedings. The opposition division was incorrect to hold that the requirements of Article 56 EPC and Article 83 EPC were met.

XII. The arguments of the respondent are summarised as follows:

Main request

Admission of allegations of fact and related lines of argument (Article 13(1) and (2) RPBA)

The appellant had not submitted any objections against the main request prior to the oral proceedings. The appellant's submissions under Articles 54, 84 and 123(2) EPC were made for the first time at oral proceedings constituted an amendment to appellant's appeal case and should not be admitted pursuant to Article 13(2) RPBA.

Amendments (Article 123(2) EPC) - claim 1

The homozygosity feature

The claims had been limited to refer to "one or both" of the immunoglobulin loci. This amendment dealt with the objections raised to the homozygous at "all three loci" feature.

The location of the light chain lambda into kappa feature in the mouse genome

Claim 1 of the main request considered by the opposition division had also been amended to specify the location of the DNA encoding the human lambda region variable DNA inserted in functional arrangement with a mouse kappa constant region, upstream of said kappa constant region, i.e the DNA feature (b) of the claim.

The LoK limitation in part (b) of the claim did not constitute added subject-matter. Basis for this feature was to be found on page 11, third full paragraph of the application as filed: "Alternatively human lambda region variable DNA might be inserted in functional arrangement with a kappa constant region, for example inserted upstream of a kappa constant region."

The amount of human lambda variable region to be inserted was not an undisclosed selection or choice either. The last paragraph of page 14 of the application as filed had a functional requirement to express "a repertoire of chimaeric antibodies, or chimaeric heavy or light chains having a mouse constant region and a human variable region". Thus, at a minimum, the "human lambda region variable DNA" to be inserted as defined in claim l(b) had to be sufficient to produce a chimaeric antibody chain and it had to comprise at least one V-lambda gene segment and at least one J-lambda gene segment, as per the disclosure of page 14.

Finally, the limitation to a targeted insertion of the light chain at the endogenous light chain locus was based on page 6, penultimate paragraph of the application as filed.

XIII. The appellant requested that the decision under appeal be set aside and the patent be revoked in its entirety.

The respondent requested that the appeal be dismissed and the patent be maintained in amended form on the basis of the set of claims of the main request, filed as auxiliary request 1 with the reply to the statement of grounds of appeal, or alternatively, the set of claims of one of auxiliary requests 1 to 7, filed as auxiliary requests 3 to 9, respectively, with the reply to the statement of grounds of appeal.

1. The appeal is admissible.

Main request - claim 1

2. In this decision reference to "mouse" should be understood to include "mouse cell", as mentioned in the claim.

Admission of new allegations of fact and related lines of argument (Article 13(1) and (2) RPBA)

3. At the oral proceedings, the appellant made submissions under Articles 54, 84 and 123(2) EPC in relation to the main request which had not been made in the written appeal procedure. The submissions on Article 123(2) EPC and Article 84 EPC relating to the part of the claim which differs from claim 1 of the previous main request (see section VIII.) relate to allegations of fact and associated lines of arguments made for the first time at the oral proceedings. All the submissions on Article 54 EPC were also made for the first time in the oral proceedings, as the appellant made reference to different passages in document D1 than when setting out the objection in the statement of grounds of appeal.

4. At oral proceedings the board, applying Article 13(1) and (2) RPBA, decided not to admit any of the above mentioned submissions under the headings of Articles 54, 84 and 123(2) EPC into the appeal proceedings.

5. Under Article 13(1) RPBA any amendment to a party's appeal case after it has filed its grounds of appeal or reply is subject to the party's justification for its amendment and may be admitted only at the discretion of the board which considers, inter alia, the current state of the proceedings, the suitability of the amendment to resolve the issues which were admissibly raised by another party in the appeal proceedings or which were raised by the board, whether the amendment is detrimental to procedural economy and in the case of an amendment to a patent application or patent, whether the party has demonstrated that any such amendment, prima facie, overcomes the issues raised by another party in the appeal proceedings or by the board and does not give rise to new objections.

6. Under Article 13(2) RPBA any amendment to a party's appeal case made after notification of a summons to oral proceedings shall, in principle, not be taken into account unless there are exceptional circumstances, which have been justified with cogent reasons by the party concerned.

7. The designation of former auxiliary request 1 as the main request was the consequence of the withdrawal of the main request by letter dated 3 November 2021 and does not constitute an exceptional circumstance pursuant to Article 13(2) RPBA. The claim request had been filed with the respondent's reply to the statement of grounds of appeal and the appellant could and should have made any submissions on this claim request as soon as possible after this date. The appellant provided no justification for not having presented the submissions in written proceedings. The appellant's reference to the absence of a time limit for presenting such submissions is of no assistance to its case. While it is true that there is no time limit for making further submissions after the statement of grounds of appeal and the reply have been filed, it is clear that under Article 13 RPBA, the later any such submissions are made, the higher the hurdle for their admission.

8. The appellant's submission of new allegations of fact and arguments concerning Articles 54, 84 and 123(2) EPC in relation to the claim request at oral proceedings confronted both the respondent and the board with new issues which had not been addressed before during the appeal proceedings. Neither the respondent nor the board could reasonably be expected to deal with these new issues in the absence of sufficient time for their proper consideration.

9. It was the appellant's own request that the former main claim request not be allowed and the foreseeable consequence of this request being successful was that auxiliary request 1 would be considered next. The appellant's decision to wait until the date of oral proceedings to present its objections led to a situation which, for reasons of procedural fairness and to ensure that the respondent's right to be heard was respected, would have necessitated giving the respondent an opportunity to react to the new objections possibly necessitating an adjournment of the oral proceedings. Such a course of action would not have been in the interest of procedural economy (Article 13(1) RPBA).

10. The appellant argued that objections under Article 123(2) EPC relating to (i) the combination of the "LoK" feature with the "heavy chain" feature in part (a) of the claim and (ii) the combination of the "LoK" feature with the "homozygous" feature had been made in writing, at least in outline, since it had been the fundamental argument presented in paragraph 4.26 of the statement of grounds of appeal which reads "...there are further issues of added matter when the light chain features are combined with the other features of claim 1 as upheld, such as the heavy chain of part (a). The overall combination of features of claim 1 as upheld does not find basis in the application as filed. The claims as upheld do not comply with Article 123(2) EPC or Article 76(1) EPC".

11. However, this paragraph does not explain which combination of features in particular is supposed to add subject-matter or why. Instead, it merely makes a general assertion, which is not equivalent to the detailed explanation given at the oral proceedings. The board therefore considered that the objections under Article 123(2) EPC submitted at the oral proceedings had not already been made in writing.

12. In relation to the objections under Article 84 EPC, the appellant submitted that no explanation for this claim request had been provided by the respondent when it was filed with the statement of grounds of appeal. In the appellant's view, explanations were only provided with letter dated 3 November 2021 in which it was stated for the first time what the feature was supposed to mean. The submissions made at the oral proceedings were therefore a prompt reaction to the respondent's late submissions.

13. This allegation is factually incorrect. An explanation (albeit a short one) of auxiliary request 1 was provided in the reply to the statement of grounds of appeal. Specifically, in paragraph 1.2 it was explained that the amendment to the claim further limited to a targeted insertion of the light chain at the endogenous light chain locus. Thus, the objection could and should have been raised earlier in the appeal proceedings. Accordingly, the board, exercising its discretion pursuant to Article 13(1) and (2) RPBA did not admit into the appeal proceedings those objections under the headings of Articles 84, 123(2) EPC and Article 54 EPC which were submitted for the first time at the oral proceedings. Only objections which were presented with the statement of grounds of appeal in relation to the main request and which clearly apply to auxiliary request 1 were taken into account.

Admission of document D27 (Article 12(4) RPBA 2007)

14. The board did not exclude document D27 from the proceedings as had been requested by the respondent during oral proceedings. However, given the board's decision on the appeal (see point 32.), the reasons for this are moot.

Amendments (Article 123(2) EPC) - claim 1

15. The descriptions of the application underlying the patent and of the parent application as filed (published as WO 2011/004192) are identical except that the former incorporates the claims of the latter as 'statements of the invention'. In the decision under appeal and in the parties' submissions on Article 123(2) EPC, reference is made only to passages in the parent application as published, with the understanding that the identical text is present in the parent application as filed and in the application as filed. For the sake of consistency with these submissions, the board continues this practice in this decision.

16. The appellant argued that the claim request considered allowable by the opposition division (see section III.), contravened the requirements of Article 123(2) EPC and that this also applied to the subject-matter claim 1 of the main request.

The homozygosity feature

17. Due to the deletion of the option homozygous at "all three loci", as compared to claim 1 of the request considered allowable by the opposition division, the appellant's objections in relation to this feature, have been rendered moot. The appellant did not dispute this view.

The location of the light chain lambda into kappa feature in the mouse genome

18. The objection relating to "where in the endogenous genome the LoK arrangement should be placed" is likewise rendered moot by the newly introduced feature "wherein the constant region is the endogenous host wild-type constant region located at the wild type locus" which now requires that the mouse kappa constant region mentioned in claim 1(b) is the endogenous host wild-type constant region.

19. The LoK arrangement for the human lambda variable region is disclosed on page 11, third full paragraph of the application as follows: "The human kappa variable region DNA might be inserted into the genome in functional arrangement with a lambda constant region, for example inserted upstream of a lambda constant region [kappa on lambda or KoL]. Alternatively human lambda region variable DNA might be inserted in functional arrangement with a kappa constant region, for example inserted upstream of a kappa constant region [lambda on kappa or LoK]". KoL and LoK are read as alternatives to "kappa on kappa" or "lambda on lambda", disclosed e.g. on page 2, paragraph 1.

20. The choice of the LoK arrangement is therefore a selection from a single list, each element of which is individually disclosed. The claimed subject-matter including the LoK feature is therefore directly and unambiguously disclosed in the application as filed.

21. The appellant also argued that if the LoK feature were at the endogenous position of kappa in the host genome, this would represent a further selection of a particular sub-type of LoK arrangement, i.e. one in which the mouse kappa sequences of the LoK are not part of the DNA that is to be inserted, but are kappa sequences that are already present in the host genome.

22. However, the board considers that basis for the limitation that the constant region is the endogenous host wild-type constant region located at the wild type locus is to be found on page 6, penultimate paragraph of the application which reads "The host non-human mammal constant region herein is preferably the endogenous host wild-type constant region located at the wild type locus, as appropriate for the heavy or light chain". Furthermore, by indicating this as a preferred option, there is also a pointer to the combination of this feature with the remaining claimed features.

23. In summary, the objections pursuant to Article 123(2) EPC set out in the statement of grounds of appeal have either been overcome by amendment or are not convincing.

Novelty (Article 54(3) EPC) - claim 1

24. The appellant challenged the opposition division's decision that the disclosure in document D1, which constituted prior art under Article 54(3) EPC, did not anticipate the subject-matter of claim 1.

25. It was common ground that documents D1 and D4 disclose mice homozygous at the modified light chain and modified heavy chain loci, respectively. It was disputed between the parties whether or not the disclosure in paragraph [00267] of document D1 amounted to a direct and unambiguous disclosure of the mice defined in claim 1, whose genome is homozygous at one or both immunoglobulin loci.

26. Paragraph [00267] of document D1 reads "Mice bearing an unrearranged human lambda light chain locus are also bred with mice that contain a replacement of the endogenous mouse heavy chain variable gene locus with the human heavy chain variable gene locus (see US 6,596,541 , Regeneron Pharmaceuticals, the VELOCIMMUNE® genetically engineered mouse). [...]. Upon a suitable breeding schedule, mice bearing a replacement of the endogenous mouse heavy chain locus with the human heavy chain locus and an unrearranged human lambda light chain locus at the endogenous kappa light chain locus is obtained".

27. The quoted sentence does not disclose the mice obtained by the "suitable breeding schedule" but rather suggests carrying out a suitable breeding. This understanding of the disclosure is supported by the fact that the breeding scheme is not precisely defined, as it would be in an example, but is referred to as a "suitable" one. Thus, the mice resulting from this breeding scheme are not disclosed but merely suggested in document D1. Since it is these mice that are purported by the appellant to be relevant to the novelty of the claimed subject-matter, the board must conclude that the disclosure in document D1 does not affect the novelty of the subject-matter of claim 1.

28. The appellant's further argument based on document D27 is that the suitable breeding scheme mentioned in paragraph [00267] of document D1 discloses the claimed mice because these are the inevitable consequence of carrying it (the breeding scheme) out. However, as is apparent from the appellant's summary of document D27 (see section XI.) which mentions that "such a schedule requires only the application of highly routine principles of mouse breeding", the arguments presented could be relevant to an allegation of obviousness but not to an allegation of lack of novelty under Article 54(3) EPC. For this reason, the argument also fails.

Objections under Articles 56 and 83 EPC

29. In the statement of grounds of appeal, objections pursuant to Articles 56 EPC and 83 EPC were briefly mentioned, however without any indication of reasons. It was merely stated in point 6.1 that "the claims as upheld also lack inventive step and/or are insufficient for essentially the reasons as set out during the opposition proceedings. The OD was incorrect to hold that the claims comply with Article 56 EPC and Article 83 EPC."

30. Such a general statement or reference does not meet the requirements under Article 12(2) RPBA 2007. According to this provision the statement of grounds of appeal should contain the appellant's complete case and set out clearly and concisely the reasons why the decision under appeal should be reversed. All the facts, arguments and evidence relied on should be specified.

31. It is the board's view that the objections relating to Articles 56 EPC and 83 EPC are not substantiated. No further relevant submissions were made in reply to the board's communication under Article 15(1) RPBA and the board thus decided not to take objections under Articles 56 and 83 EPC into account in these appeal proceedings in accordance with Article 12(4) RPBA 2007.

32. In view of the considerations set out above, the patent with claim 1 meets the requirements of the EPC and the appeal is thus not allowable. Since the appellant has not submitted separate objections against any of claims 2 to 14 of the main request, the patent may be maintained on the basis of the set of claims of the main request.

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division with the order to maintain the patent in amended form with the set of claims 1 to 14 of the main request, filed as auxiliary request 1 with the reply to the statement of grounds of appeal, and a description and drawings to be adapted thereto.

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility